cistidep sachet
Ingredients:
Inulin, D-mannose (from Betula
pendula bark), CystiCran™40 – Cranberry (Vaccinium macrocarpon)
extract, Vitamin C, Pido-Zinc® (Zinc pidolate), Berryvin™ – standardized mixed
fruit extract, Fragaria ananassa (strawberry), Vaccinium myrtillus (bilberry), Malpighia glabra (acerola), Rubus fruticosus (blackberry), Vaccinium macrocarpon (cranberry), Vitis vinifera (grape), Punica granatum (pomegranate) and others.
Properties
Cistidep® combines natural
bioactive compounds with antioxidant, anti-adhesive, and mucosal-protective
properties to promote urinary tract health and reduce recurrence of infections.
D-mannose: A natural monosaccharide that prevents bacterial adhesion, particularly Escherichia
coli, to the urothelial mucosa, thereby reducing colonization and infection
recurrence.
CystiCran™40 (Cranberry extract): Rich in proanthocyanidins (PACs), which inhibit bacterial adhesion mechanisms
in the urinary tract and support mucosal integrity through strong antioxidant
action.
Inulin: A prebiotic fibre that supports intestinal microbiota balance, indirectly
promoting urinary tract health by modulating immune and inflammatory responses.
Vitamin C: Provides antioxidant and immune-supporting effects, helps acidify urine, and
enhances the activity of other plant-based antioxidants.
Pido-Zinc® (Zinc pidolate): Delivers bioavailable zinc, essential for immune defense and tissue repair,
contributing to resistance against recurrent infections.
Berryvin™ (Mixed fruit
polyphenolic complex): A rich source of anthocyanins and polyphenols with broad-spectrum antioxidant,
anti-inflammatory, and vascular-protective activity that enhances urinary and
systemic wellness.
Indications
Cistidep® is recommended for:
Prevention and adjunctive
management of recurrent urinary tract infections (UTIs), especially those
caused by E. coli
Supportive therapy in cystitis,
urethritis, and post-antibiotic recovery
Protection of the urinary
epithelium and reduction of inflammation-related discomfort (burning, urgency,
frequency)
Maintenance of urinary tract
health in women prone to recurrent infections (including post-menopausal and
sexually active women)